Cell type-specific responses to interferon-β: implications for understanding the mechanism of interferon-β therapy in multiple sclerosis

被引：0
|
作者：
van Boxel-Dezaire, Anette H. H. [1 ]
Fisher, Elizabeth [2 ]
Ransohoff, Richard M. [3 ]
Rudick, Richard A. [4 ]
Stark, George R. [1 ]
机构：
[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA
[3] Cleveland Clin Fdn, Lerner Res Inst, Neuroinflammat Res Ctr, Cleveland, OH 44195 USA
[4] Cleveland Clin Fdn, Neurol Inst, Cleveland, OH 44195 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2010年 / 16卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：997 / 998
页数：2
相关论文
共 50 条
  • [21] Interferon-α/interferon-α-2bFirst report of multiple sclerosis: case report
    Reactions Weekly, 2002, 919 (1) : 7 - 7
  • [22] Interferon-β mechanisms of action in multiple sclerosis
    Dhib-Jalbut, Suhayl
    Marks, Steven
    NEUROLOGY, 2010, 74 (01) : S17 - S24
  • [23] Treatment recommendations for interferon-β in multiple sclerosis
    Polman, CH
    Miller, DH
    McDonald, WI
    Thompson, AJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (05): : 561 - 564
  • [24] Interferon-β treatment for relapsing multiple sclerosis
    Weinstock-Guttman, Bianca
    Ramanathan, Murali
    Zivadinov, Robert
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (09) : 1435 - 1447
  • [25] Interferon-β increases BAFF levels in multiple sclerosis:: implications for B cell autoimmunity
    Krumbholz, M.
    Faber, H.
    Steinmeyer, F.
    Hoffmann, L. -A.
    Kuempfel, T.
    Pellkofer, H.
    Derfuss, T.
    Ionescu, C.
    Starck, M.
    Hafner, C.
    Hohlfeld, R.
    Meinl, E.
    BRAIN, 2008, 131 : 1455 - 1463
  • [26] Endogenous Interferon-β-Inducible Gene Expression and Interferon-β-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis
    Boernsen, Lars
    Christensen, Jeppe Romme
    Ratzer, Rikke
    Hedegaard, Chris
    Sondergaard, Helle B.
    Krakauer, Martin
    Hesse, Dan
    Nielsen, Claus H.
    Sorensen, Per S.
    Sellebjerg, Finn
    PLOS ONE, 2015, 10 (03):
  • [27] Binding antibodies to interferon-β in Iranian multiple sclerosis patients treated with different interferon-β preparations
    Vaezeafshar, R
    Hooshmand, E
    Jangouk, P
    Amirzargar, A
    Nikbin, B
    Lotfi, J
    Soltanzodeh, S
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S253 - S253
  • [28] Plasma fibrinogen in multiple sclerosis patients after interferon-β therapy
    Sena, A
    Pedrosa, R
    Azevedo, J
    Cascais, M
    Sena, V
    Couderc, R
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S237 - S237
  • [29] A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
    Comabella, M.
    Luenemann, J. D.
    Rio, J.
    Sanchez, A.
    Lopez, C.
    Julia, E.
    Fernandez, M.
    Nonell, L.
    Camina-Tato, M.
    Deisenhammer, F.
    Caballero, E.
    Tortola, M. T.
    Prinz, M.
    Montalban, X.
    Martin, R.
    BRAIN, 2009, 132 : 3353 - 3365
  • [30] In-vivo response to interferon-α is preserved in multiple sclerosis patients with neutralising antibodies against interferon-β
    Magyari, M.
    Sondergaard, H. Bach
    Sellebjerg, F.
    Sorensen, P. Soelberg
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 202 - 202
12345